Skip to main content
Premium Trial:

Request an Annual Quote

Martine Piccart, Christos Sotiriou, Anne-Lise Børresen-Dale, Alan Hollingsworth, David Barker, and Mostafa Ronaghi

Premium
DiaGenic this week said that four international experts on breast cancer have joined its scientific advisory board.
 
The Norwegian diagnostics company named Martine Piccart and Christos Sotiriou,both professors of oncology at the Université Libre de Bruxelles in Brussels, Anne-Lise Børresen-Dale, head of the department of genetics at the Norwegian Radium Hospital in Oslo, Norway, and Alan Hollingsworth, the medical director of Mercy Women’s Center of Oklahoma City, to its SAB.
 

 
Microchip Biotechnologies, an early-stage company developing nanofluidic sample preparation and analysis tools, has named David Barker and Mostafa Ronaghi to its board of directors.
 

Barker is vice president and chief scientific officer of Illumina. Ronaghi is the co-founder of several biotech companies, including Pyrosequencing, ParAllele Biosciences, and NextBio. He is currently a principal investigator at the Stanford University Genome Center.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.